10-Q: Bowhead Specialty Soars: Q3 Net Income Up 25.5%

Bowhead Specialty Holdings Inc. reported robust financial results for Q3 and the first nine months of 2025, driven by significant premium growth and increased net investment income.

Summary

• Net income for the three months ended September 30, 2025, increased by 25.5% to $15.2 million, up from $12.1 million in the prior year period.
• For the nine months ended September 30, 2025, net income surged by 58.1% to $38.9 million, compared to $24.6 million in the same period of 2024.
• Gross written premiums grew by 17.5% to $231.5 million for the three months and 25.0% to $638.7 million for the nine months ended September 30, 2025.
• Net earned premiums increased by 22.1% to $128.4 million for the three months and 28.4% to $357.4 million for the nine months ended September 30, 2025.
• Net investment income rose by 30.9% to $15.0 million for the three months and 47.8% to $41.3 million for the nine months ended September 30, 2025.
• The combined ratio for the three months ended September 30, 2025, was 95.4%, an increase of 1.0 point, while for the nine months, it improved by 0.6 points to 96.4%.
• Return on equity increased to 14.5% for the three months and 13.0% for the nine months ended September 30, 2025.
• Total assets increased to $2.09 billion as of September 30, 2025, from $1.65 billion at December 31, 2024.
• Total mezzanine equity and stockholders' equity increased to $431.0 million as of September 30, 2025, from $370.4 million at December 31, 2024.

Sentiment

Score: 8

Explanation: The company delivered strong financial performance with significant growth in premiums, net income, and investment income. While the loss ratio increased, the overall improvement in expense ratio (over nine months) and return on equity indicates effective management and a positive trajectory. The balance sheet also strengthened considerably.

Positives

• Net income increased significantly by 25.5% for the three months and 58.1% for the nine months ended September 30, 2025.
• Gross written premiums showed strong growth of 17.5% for the three months and 25.0% for the nine months, driven by increasing renewal business and platform expansion across all divisions.
• Net investment income saw substantial increases of 30.9% for the three months and 47.8% for the nine months, attributed to a higher average balance of investments and improved yields.
• The expense ratio decreased by 0.4 points to 29.5% for the three months and 1.8 points to 30.1% for the nine months, reflecting business scaling and prudent expense management.
• The combined ratio improved by 0.6 points to 96.4% for the nine months ended September 30, 2025.
• Return on equity increased by 0.8 points to 14.5% for the three months and 1.2 points to 13.0% for the nine months.
• Total assets grew by $440.3 million, and total equity increased by $60.6 million, indicating a strengthening financial position.

Negatives

• The loss ratio increased by 1.4 points to 65.9% for the three months and 1.2 points to 66.3% for the nine months ended September 30, 2025, primarily due to changes in portfolio mix towards the Casualty division and prior accident year audit premiums.
• The combined ratio for the three months ended September 30, 2025, increased by 1.0 point to 95.4%.
• Net acquisition costs ratio increased by 1.1 points for the three months and 0.9 points for the nine months, driven by higher Ceding Fees and earned broker commissions due to portfolio mix changes.

Risks

• Inability to accurately assess underwriting risk.
• Intense competition within the industry.
• Inability to maintain the strategic relationship with American Family Mutual Insurance Company, S.I. (AmFam).
• A decline in AmFam's financial strength rating or financial size category.
• Exposure to risks arising from reliance on insurance retail agents, brokers, and wholesalers as distribution channels.
• Inadequate losses and loss expense reserves to cover actual losses.
• Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, in policies.
• Reinsurers' failure to reimburse claims on a timely basis, or at all.
• Adverse economic factors and their impact on growth and profitability.
• Existing or future regulation and the ability to comply with these regulations.
• Loss of one or more key personnel.
• Disruptions of operations due to security breaches, loss of data, cyber-attacks, and other information technology failures.
• Increased costs as a result of operating as a public company.

Future Outlook

Forward-looking statements indicate intentions, beliefs, or current expectations regarding consolidated results, financial condition, liquidity, growth strategies, and industry operations, but are subject to known and unknown risks and uncertainties, many of which are beyond the company's control.

Management Comments

• Our principal objective is to create and sustain superior returns for our stockholders by generating consistent, underwriting profits across our product offerings and through all market cycles, while prudently managing capital.
• We believe that our current market opportunity, differentiated expertise, relationships, culture and leadership team position us well to continue to grow our business profitably.

Industry Context

The company operates in the U.S. specialty property and casualty (P&C) insurance market, focusing on Casualty, Professional Liability, and Healthcare Liability risks, primarily on a non-admitted (excess and surplus, E&S) basis. This allows for flexibility in adjusting to market opportunities. The reported growth across all divisions, particularly in Casualty and Baleen Specialty, suggests the company is effectively capitalizing on favorable pricing environments and unmet demand for specialized insurance solutions.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or global benchmarks for its performance.
• It notes that its Casualty division has 'comparatively higher current accident year industry loss ratios', indicating an awareness of industry benchmarks for this segment.

Legal Proceedings

• The company is subject to routine legal proceedings in the normal course of operating its insurance business.
• No current claims, lawsuits, or proceedings are expected to have a material adverse effect on the company's business, results of operations, or financial condition.

Related Party Transactions

• American Family Mutual Insurance Company, S.I. (AmFam) beneficially owns approximately 14.3% of the company's issued and outstanding common stock.
• Bowhead Insurance Company, Inc. (BICI) assumes 100% of premiums, net of third-party reinsurance, through a Quota Share Agreement with AFMIC (an AmFam subsidiary).
• AmFam receives a ceding fee on net premiums assumed by BICI.
• BICI provides collateral to support obligations of the AmFam Quota Share Agreement via an Insurance Trust Agreement.
• Bowhead Specialty Underwriters, Inc. (BSUI) issues insurance policies and provides services on behalf of AmFam Issuing Carriers, receiving commissions.
• Bowhead ceded $9.3 million (Q3 2025) and $25.6 million (9 months 2025) of written premiums to a subsidiary of AmFam under ceded reinsurance treaties.
• The company incurred $3.9 million (Q3 2025) and $9.3 million (9 months 2025) in Ceding Fees under the AmFam Quota Share Agreement.
• On August 6, 2025, the company entered into a usage-based service agreement with Bold Penguin, an insuretech company owned by AmFam, incurring $0.1 million in operating expenses for the three and nine months ended September 30, 2025.
• Warrants to purchase common stock were issued to AmFam on May 22, 2024, and May 28, 2024.

Stakeholder Impact

• Shareholders: Benefit from increased net income, diluted EPS, and return on equity, indicating improved profitability and value creation.
• Employees/Management: Benefit from stock-based compensation plans (RSUs, PSUs, Warrants) tied to company performance and continued service.
• Customers/Policyholders: Benefit from the company's focus on specialized insurance solutions and quality service, supported by growth across underwriting divisions.
• Reinsurers: Continue to be key partners, with the company maintaining relationships with highly-rated reinsurers (A.M. Best A or better).
• Brokers/Distribution Partners: Continue to be critical distribution channels, with commissions being a significant acquisition cost.

Next Steps

• The company intends to renew its reinsurance treaties on similar terms as expiring to maintain its desired level of net risk appetite.
• Reinsurance coverage terms or the composition of the reinsurance panel may be adjusted during each renewal cycle based on various factors including plans to change underlying insurance coverage, loss activity trends, capital and surplus levels, risk appetite, and cost/availability of reinsurance.

Key Dates

Recommendation

The company demonstrated robust growth in gross and net written premiums, coupled with a significant increase in net income and return on equity for both the three and nine months ended September 30, 2025. While the loss ratio saw a slight increase, the overall operational scaling and prudent expense management led to an improved expense ratio over the nine-month period and a favorable combined ratio trend. The strong investment income and healthy balance sheet further support a positive outlook, suggesting continued value creation for shareholders.

Keywords

Specialty insurance, P&C insurance, Underwriting, Reinsurance, Casualty insurance, Professional liability, Healthcare liability, Baleen Specialty, Financial results, Q3 2025, SEC filing, 10-Q, Bowhead Specialty, Gross written premiums, Net income, Combined ratio, Return on equity